While the question remains about how a low level of EpoR can provide a direct EPO response, various responses to EPO observed in animal and cell models of ischemic stress, injury or metabolism in non-hematopoietic tissues suggest therapeutic benefit for EPO beyond anemia. The gene discussed is EPOR; the disease is anemia.